Boehringer streamlines NGS through partnershipNovember 14, 2019An enhanced partnership between Boehringer Ingelheim and biopharmaceutical research and development (R&D) provider, Genedata, is set to automate the pharmaceutical company’s complex cell line development processes.
SPONSORED CONTENTSee What the ACVIM Recommends for Certain Types of Canine CHFSafe, effective treatment that's approved by the FDA for management of certain types of canine CHF. + Learn More